Bullish indicating open at $55-$60, IPO prices at $37
In a recent transaction, John A. Moore, Chairman of the Board at Scientific Industries Inc. (NASDAQ:SCND), acquired a significant number of shares in the company. According to InvestingPro analysis, the stock is currently trading at $0.8, suggesting the Chairman’s investment comes at an opportune time as the company shows promising prospects, with analysts forecasting profitability this year. According to the SEC filing, Moore purchased 35,000 shares of common stock at a price of $1 per share, amounting to a total transaction value of $35,000. This purchase was part of a broader transaction that also included warrants to acquire an additional 35,000 shares of common stock at the same exercise price. Following these transactions, Moore’s total direct ownership stands at 386,690 shares. The company, currently valued at $8.4M market cap, maintains a FAIR financial health score according to InvestingPro’s comprehensive analysis, which includes 7 additional key insights available to subscribers.
In other recent news, Scientific Industries reported a challenging start to fiscal year 2025, marked by a decline in revenue within its bioprocessing segment. Despite this setback, the company successfully raised $1.5 million in new financing, which will support ongoing product innovation initiatives, including the development of the FBI DOTS sensor platform. The company also achieved a 17% reduction in quarterly cash demand, contributing to a slight improvement in net loss due to lower operating expenses. Scientific Industries is focusing on expanding its market in mammalian cell culture workflows as it anticipates a market rebound in the latter half of 2025 and into 2026. The company has been actively working on new product developments, including a high-performance liquid injection system and a miniaturized biomass sensor. Executive leadership at Scientific Industries emphasized the importance of integrated, digitally native platforms to drive industrial efficiency. The company continues to navigate macroeconomic pressures, with cautious market spending and funding delays in academic and startup sectors presenting ongoing challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.